Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy
Nitric oxide (NO), as a gaseous therapeutic agent, shows great potential for the treatment of many kinds of diseases. Although various NO delivery systems have emerged, the immunogenicity and long-term toxicity of artificial carriers hinder the potential clinical translation of these gas therapeutic...
Main Authors: | Haoyan Huang, Meng Qian, Yue Liu, Shang Chen, Huifang Li, Zhibo Han, Zhong-Chao Han, Xiang-Mei Chen, Qiang Zhao, Zongjin Li |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2023-09-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/84820 |
Similar Items
-
Nitric Oxide Nano-Delivery Systems for Cancer Therapeutics: Advances and Challenges
by: Long Binh Vong, et al.
Published: (2020-08-01) -
Local delivery of gaseous signaling molecules for orthopedic disease therapy
by: Jiaxuan Sun, et al.
Published: (2023-02-01) -
Nitric oxide in kidney transplantation
by: George J. Dugbartey
Published: (2023-11-01) -
Gaseous signaling molecule-releasing hybrid nanomaterials for therapeutic applications
by: Ishaq Lugoloobi, et al.
Published: (2023-06-01) -
Nitric Oxide Production and Apoptosis Induction in T Cells through Stimulation of Mesenchymal Stem Cells with Zymosan
by: Elham darabi, et al.
Published: (2015-05-01)